[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100592207":3},{"organization":4,"armGroups":7,"interventions":19,"overallOfficials":30,"centralContacts":34,"locations":40,"responsibleParty":105,"collaborators":25,"id":107,"slug":25,"hasResults":108,"nctId":109,"briefTitle":110,"officialTitle":110,"acronym":111,"eligibilityCriteria":112,"healthyVolunteers":108,"sex":113,"minAge":114,"maxAge":25,"enrollmentInfo":115,"targetDuration":25,"studyType":118,"phases":119,"briefSummary":121,"conditions":122,"keywords":124,"overallStatus":43,"whyStopped":25,"lastUpdateSubmitDate":128,"lastUpdatePostDateStruct":129,"startDateStruct":132,"completionDateStruct":134,"leadSponsor":136,"locationsCount":137},{"fullName":5,"class":6},"The Cleveland Clinic","OTHER",[8,14],{"label":9,"type":10,"description":11,"interventionNames":12},"Groin closure after vascular intervention with PDS suture","ACTIVE_COMPARATOR","Vascular intervention access site closed with PDS suture",[13],"Procedure: Groin closure with PDS suture",{"label":15,"type":10,"description":16,"interventionNames":17},"Groin closure after vascular intervention with Vicryl suture","Vascular intervention access site closure with Vicryl suture",[18],"Procedure: Groin closure suture material",[20,26],{"type":21,"name":22,"description":23,"armGroupLabels":24,"otherNames":25},"PROCEDURE","Groin closure with PDS suture","Closure of the groin will be performed with PDS suture",[9],null,{"type":21,"name":27,"description":28,"armGroupLabels":29,"otherNames":25},"Groin closure suture material","Closure of the groin will be performed with Vicryl suture",[15],[31],{"name":32,"affiliation":5,"role":33},"Francis Caputo, MD","PRINCIPAL_INVESTIGATOR",[35],{"name":36,"role":37,"phone":38,"phoneExt":25,"email":39},"Ahmed Sorour, MD","CONTACT","216-399-9224","SOROURA2@ccf.org",[41],{"facility":42,"status":43,"city":44,"state":45,"zip":46,"country":47,"cosmosGeoPoint":48,"geoPoint":53,"contacts":54},"Cleveland Clinic","RECRUITING","Cleveland","Ohio","44195","United States",{"type":49,"coordinates":50},"Point",[51,52],-81.69541,41.4995,{"lat":52,"lon":51},[55,56,57,59,61,63,65,67,69,71,73,75,77,79,81,83,85,87,89,91,93,95,97,99,101,103],{"name":36,"role":37,"phone":38,"phoneExt":25,"email":39},{"name":32,"role":33,"phone":25,"phoneExt":25,"email":25},{"name":36,"role":58,"phone":25,"phoneExt":25,"email":25},"SUB_INVESTIGATOR",{"name":60,"role":58,"phone":25,"phoneExt":25,"email":25},"Jon Quatromoni, MD",{"name":62,"role":58,"phone":25,"phoneExt":25,"email":25},"Ali Khalifeh, MD",{"name":64,"role":58,"phone":25,"phoneExt":25,"email":25},"Ravi Ambani, MD",{"name":66,"role":58,"phone":25,"phoneExt":25,"email":25},"Courtney Hanak, MD",{"name":68,"role":58,"phone":25,"phoneExt":25,"email":25},"Nicohlas Hoell, MD",{"name":70,"role":58,"phone":25,"phoneExt":25,"email":25},"Reinis Ozolins, MD",{"name":72,"role":58,"phone":25,"phoneExt":25,"email":25},"Connor Crudeli, MD",{"name":74,"role":58,"phone":25,"phoneExt":25,"email":25},"Thomas Perry, MD",{"name":76,"role":58,"phone":25,"phoneExt":25,"email":25},"Emma Fulton, MD",{"name":78,"role":58,"phone":25,"phoneExt":25,"email":25},"Nathan Reinert, MD",{"name":80,"role":58,"phone":25,"phoneExt":25,"email":25},"John Taaffe, MD",{"name":82,"role":58,"phone":25,"phoneExt":25,"email":25},"Keith Garber, MD",{"name":84,"role":58,"phone":25,"phoneExt":25,"email":25},"Bryan Cass, MD",{"name":86,"role":58,"phone":25,"phoneExt":25,"email":25},"Brendan Jones, MD",{"name":88,"role":58,"phone":25,"phoneExt":25,"email":25},"Michael Gibbons, MD",{"name":90,"role":58,"phone":25,"phoneExt":25,"email":25},"Blake Westling, MD",{"name":92,"role":58,"phone":25,"phoneExt":25,"email":25},"Abdullah Khan, MD",{"name":94,"role":58,"phone":25,"phoneExt":25,"email":25},"Ryan Ellis, MD",{"name":96,"role":58,"phone":25,"phoneExt":25,"email":25},"Lee Kirksey, MD",{"name":98,"role":58,"phone":25,"phoneExt":25,"email":25},"Sami Abou-Assi, MD",{"name":100,"role":58,"phone":25,"phoneExt":25,"email":25},"Antoine Marc, MD",{"name":102,"role":58,"phone":25,"phoneExt":25,"email":25},"D'Andre Williams, MD",{"name":104,"role":58,"phone":25,"phoneExt":25,"email":25},"Alice Alexander, MD",{"type":33,"investigatorFullName":32,"investigatorTitle":106,"investigatorAffiliation":5,"oldNameTitle":25,"oldOrganization":25},"Principal Investigator","100592207",false,"NCT06990425","CLOSM Trial: Groin Closure Using Layered Option for Suture Material","CLOSM","Inclusion Criteria:\n\n* All patients \\> 18 years who undergo ELECTIVE vascular surgery that would require groin incisions\n* Patients with to undergo ELECTIVE bilateral groin incisions will be matched to receive closure with PDS in one groin and Vicryl in the other groin\n\nExclusion Criteria:\n\n1. Age 17 or younger\n2. Prisoners\n3. Pregnant patients\n4. Emergent cases\n5. Active groin infection prior to intervention\n6. History of prior surgical groin access (re-operative groin)\n7. Groin closure after extracorporeal membrane oxygenation (ECMO)","ALL","18 Years",{"count":116,"type":117},259,"ESTIMATED","INTERVENTIONAL",[120],"NA","This is a randomized controlled trial comparing groin closure after vascular intervention with Vicryl suture versus PDS (polydioxanone) suture. This will be a single center trail performed at CCF main campus. Patients will be enrolled in a prospective fashion and will be randomized 1:1 to either PDS or Vicryl closure. Patients undergoing bilateral groin exposure will be randomized to receive both closure types to either groin.",[123],"Vascular Diseases",[125,126,127],"surgical site complication","vascular surgery","wound healing","2026-06-01",{"date":130,"type":131},"2026-06-03","ACTUAL",{"date":133,"type":131},"2025-03-27",{"date":135,"type":117},"2027-12-31",{"name":5,"class":6},1]